BMRN vs KYMR
BioMarin Pharmaceutical Inc. · Kymera Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | BMRN | KYMR |
|---|---|---|
| Price | $62.21 | $115.47 |
| Market Cap | $12.04B | $9.60B |
| P/E | 34.51 | — |
| P/B | 1.90 | 6.36 |
| P/S | 3.74 | 244.87 |
| ROE | 5.5% | -20.6% |
| Net Margin | 10.8% | -794.0% |
| Gross Margin | — | — |
| Revenue Growth | 12.9% | -16.7% |
| Dividend Yield | — | — |
| EPS | $1.80 | -$3.74 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.